LiP-MS, A Machine Learning-based Chemoproteomic Approach to Identify Drug Targets in Complex Proteomes | Biognosys
Contact us Helpdesk

LiP-MS, A Machine Learning-based Chemoproteomic Approach to Identify Drug Targets in Complex Proteomes

Slide Deck from Minisymposium #21 at AACR 2021

Presenter: Nigel Beaton
A collaboration with:  AstraZeneca, ETH Zurich

Minisymposium session April 11, 3:35 PM US EDT: MS.CH01.01 – Cancer Proteomics and Screening Technologies

Abstract

 

 

Back to Resources overview